Clinical Trial

Feasibility, Accuracy, and Reproducibility of Virtual Reality Visual Field Testing in Patients With Glaucoma

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 14, 2025 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to evaluate the feasibility of using virtual reality based visual field testing to monitor glaucoma in a clinical setting. This will be done through comparison of a virtual reality (VR) based device to the current gold standard Ziess Humphrey Field Analyzer (HFA). The main questions the study aims to answer are: * Can both devices produce similar results in terms of detecting visual field defects and progression? * Does the stage (early, moderate, advanced) of glaucoma impact results between the two devices? Participants will perform both a standard and a VR based visual field test at each visit, for a total of 5 visits.
Trial Details
NCT Number NCT07063537
Lead Sponsor Nova Scotia Health Authority
Conditions Glaucoma Open-Angle
Enrollment 60 participants
Start Date 2024-12-14
Primary Completion 2025-10 (estimated)
Study Completion 2025-10 (estimated)
Updated on ClinicalTrials.gov 2025-07-14